336 related articles for article (PubMed ID: 30760405)
21. Chicoric acid alleviates lipopolysaccharide-induced acute lung injury in mice through anti-inflammatory and anti-oxidant activities.
Ding H; Ci X; Cheng H; Yu Q; Li D
Int Immunopharmacol; 2019 Jan; 66():169-176. PubMed ID: 30466029
[TBL] [Abstract][Full Text] [Related]
22. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
[TBL] [Abstract][Full Text] [Related]
23. Cavidine Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via NF-κB Signaling Pathway in vivo and in vitro.
Niu X; Liu F; Li W; Zhi W; Zhang H; Wang X; He Z
Inflammation; 2017 Aug; 40(4):1111-1122. PubMed ID: 28365871
[TBL] [Abstract][Full Text] [Related]
24. Knockdown of TFPI-Anchored Endothelial Cells Exacerbates Lipopolysaccharide-Induced Acute Lung Injury Via NF-κB Signaling Pathway.
Wang BQ; Shi M; Zhang JP; Wu X; Chang MJ; Chen ZH; Shen HH; Song YL; Zhou J; Bai CX
Shock; 2019 Feb; 51(2):235-246. PubMed ID: 29438223
[TBL] [Abstract][Full Text] [Related]
25. Preventive and therapeutic effects of Danhong injection on lipopolysaccharide induced acute lung injury in mice.
Wan LM; Tan L; Wang ZR; Liu SX; Wang YL; Liang SY; Zhong JB; Lin HS
J Ethnopharmacol; 2013 Aug; 149(1):352-9. PubMed ID: 23850708
[TBL] [Abstract][Full Text] [Related]
26. Protective effect of taraxasterol on acute lung injury induced by lipopolysaccharide in mice.
San Z; Fu Y; Li W; Zhou E; Li Y; Song X; Wang T; Tian Y; Wei Z; Yao M; Cao Y; Zhang N
Int Immunopharmacol; 2014 Apr; 19(2):342-50. PubMed ID: 24548765
[TBL] [Abstract][Full Text] [Related]
27. Puerarin prevents LPS-induced acute lung injury via inhibiting inflammatory response.
Wang X; Yan J; Xu X; Duan C; Xie Z; Su Z; Ma H; Ma H; Wei X; Du X
Microb Pathog; 2018 May; 118():170-176. PubMed ID: 29571724
[TBL] [Abstract][Full Text] [Related]
28. Aucubin protects against lipopolysaccharide-induced acute pulmonary injury through regulating Nrf2 and AMPK pathways.
Qiu YL; Cheng XN; Bai F; Fang LY; Hu HZ; Sun DQ
Biomed Pharmacother; 2018 Oct; 106():192-199. PubMed ID: 29958143
[TBL] [Abstract][Full Text] [Related]
29. Protective effects of pogostone against LPS-induced acute lung injury in mice via regulation of Keap1-Nrf2/NF-κB signaling pathways.
Sun CY; Xu LQ; Zhang ZB; Chen CH; Huang YZ; Su ZQ; Guo HZ; Chen XY; Zhang X; Liu YH; Chen JN; Lai XP; Li YC; Su ZR
Int Immunopharmacol; 2016 Mar; 32():55-61. PubMed ID: 26800098
[TBL] [Abstract][Full Text] [Related]
30. Peroxisome proliferator-activated receptor gamma coactivator-1α/HSF1 axis effectively alleviates lipopolysaccharide-induced acute lung injury via suppressing oxidative stress and inflammatory response.
Dang X; Du G; Hu W; Ma L; Wang P; Li Y
J Cell Biochem; 2019 Jan; 120(1):544-551. PubMed ID: 30216506
[TBL] [Abstract][Full Text] [Related]
31. Isorhamnetin protects mice from lipopolysaccharide-induced acute lung injury via the inhibition of inflammatory responses.
Chi G; Zhong W; Liu Y; Lu G; Lü H; Wang D; Sun F
Inflamm Res; 2016 Jan; 65(1):33-41. PubMed ID: 26525359
[TBL] [Abstract][Full Text] [Related]
32. Hydrogen inhalation ameliorates lipopolysaccharide-induced acute lung injury in mice.
Qiu X; Li H; Tang H; Jin Y; Li W; YuSun ; PingFeng ; Sun X; Xia Z
Int Immunopharmacol; 2011 Dec; 11(12):2130-7. PubMed ID: 22015602
[TBL] [Abstract][Full Text] [Related]
33. Total flavonoids of Mosla scabra leaves attenuates lipopolysaccharide-induced acute lung injury via down-regulation of inflammatory signaling in mice.
Chen J; Wang JB; Yu CH; Chen LQ; Xu P; Yu WY
J Ethnopharmacol; 2013 Jul; 148(3):835-41. PubMed ID: 23747643
[TBL] [Abstract][Full Text] [Related]
34. Combination therapy with nitric oxide and molecular hydrogen in a murine model of acute lung injury.
Liu H; Liang X; Wang D; Zhang H; Liu L; Chen H; Li Y; Duan Q; Xie K
Shock; 2015 May; 43(5):504-11. PubMed ID: 25643010
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-92a antagonism attenuates lipopolysaccharide (LPS)-induced pulmonary inflammation and injury in mice through suppressing the PTEN/AKT/NF-κB signaling pathway.
Fu L; Zhu P; Qi S; Li C; Zhao K
Biomed Pharmacother; 2018 Nov; 107():703-711. PubMed ID: 30138892
[TBL] [Abstract][Full Text] [Related]
36. Plasminogen activator inhibitor type-1 deficiency exaggerates LPS-induced acute lung injury through enhancing Toll-like receptor 4 signaling pathway.
Hua F; Ren W; Zhu L
Blood Coagul Fibrinolysis; 2011 Sep; 22(6):480-6. PubMed ID: 21577093
[TBL] [Abstract][Full Text] [Related]
37. TRAF1 regulates recruitment of lymphocytes and, to a lesser extent, neutrophils, myeloid dendritic cells and monocytes to the lung airways following lipopolysaccharide inhalation.
Oyoshi MK; Barthel R; Tsitsikov EN
Immunology; 2007 Mar; 120(3):303-14. PubMed ID: 17328785
[TBL] [Abstract][Full Text] [Related]
38. Digitoflavone (DG) attenuates LPS-induced acute lung injury through reducing oxidative stress and inflammatory response dependent on the suppression of TXNIP/NLRP3 and NF-κB.
Meng M
Biomed Pharmacother; 2017 Oct; 94():712-725. PubMed ID: 28800542
[TBL] [Abstract][Full Text] [Related]
39. Sclareol ameliorate lipopolysaccharide-induced acute lung injury through inhibition of MAPK and induction of HO-1 signaling.
Hsieh YH; Deng JS; Pan HP; Liao JC; Huang SS; Huang GJ
Int Immunopharmacol; 2017 Mar; 44():16-25. PubMed ID: 28068646
[TBL] [Abstract][Full Text] [Related]
40. Clausena anisata-mediated protection against lipopolysaccharide-induced acute lung injury in mice.
Jeon CM; Shin IS; Shin NR; Hong JM; Kwon OK; Kim JH; Oh SR; Bach TT; Hai DV; Quang BH; Choi SH; Lee J; Myung PK; Ahn KS
Int J Mol Med; 2016 Apr; 37(4):1091-8. PubMed ID: 26952971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
